文献速递妇科

一项系统综述:确定子宫内膜异位症健康量表在测量子宫内膜异位症女性生活质量结局中的应用

A systematic review to determine use of the Endometriosis Health Profiles to measure quality of life outcomes in women with endometriosis.
PubMed 文献 · Hum Reprod Update · 2024-01-01

该研究系统综述了139篇使用子宫内膜异位症健康量表(EHP-30和EHP-5)的论文,评估其应用目的、研究特征、方法学质量及干预后的EHP结局。多数女性治疗后健康相关生活质量改善,手术干预改善持续时间最长,EHP-30心理测量学特性得到支持,但因异质性未进行Meta分析。

要点

  • EHP量表主要用于测量药物(35项)和手术(21项)治疗结局。
  • 多数女性治疗后健康相关生活质量改善,手术干预改善持续时间最长。
  • EHP-30心理测量学特性(包括跨文化效度)得到支持,EHP-5可能更适合常规临床实践。

核心结论

  • EHP是可靠、有效、可接受且反应性良好的工具,但需在现代心理测量方法及多样化族群和常规临床护理中进一步评估。
  • 鉴于EHP-5简短,它可能是常规临床实践中最合适的版本,而更长的EHP-30提供更多细节,更适合研究。

研究设计与样本

  • 系统综述,遵循PRISMA指南,检索MEDLINE、CINAHL、PsycINFO、PubMed和Google Scholar从2001年至2020年2月26日,并于2021年4月9日更新,纳入139篇论文,使用混合方法评估工具(MMAT)进行质量评价。

主要发现

  • 在临床干预研究中,EHP最常用于测量药物治疗(n=35)和手术治疗(n=21)的结局;还用于13项其他干预研究、29项非干预研究、32项心理测量/跨文化验证研究、6项诊断研究和3项其他研究。
  • 总体而言,无论干预性质如何,大多数女性报告治疗后健康相关生活质量改善;手术干预通常带来最长时间的显著改善;有证据表明当参与者停止服药时EHP评分恶化,可能强化了药物治疗的暂时效果;年轻患者报告健康相关生活质量受到更多负面影响。
  • 使用锚定法,EHP-30反应性研究显示干预后「控制与无力感」领域平均变化最大,其次是「疼痛」。
  • MMAT结果显示除5项研究外,论文质量良好;由于干预措施和纳入论文的异质性,未进行Meta分析。

关键数值与推荐

  • EHP-30在可接受性、维度性、信度、效度(包括跨文化)和反应性方面得到经典测试理论的支持。

临床怎么用

  • 鉴于EHP-5简短,它可能是常规临床实践中最合适的版本,而更长的EHP-30提供更多细节,更适合研究。

局限性

  • 由于干预措施和纳入论文的异质性,未进行Meta分析。
  • 需要更多使用现代心理测量方法、在多样化族群背景和常规临床护理中评估EHP结局的研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Endometriosis Health Profiles (EHPs), the EHP-30 and EHP-5, are patient-reported outcome measures that were developed to measure the health-related quality of life (HRQoL) of women living with endometriosis. Prior to their development, a systematic review was undertaken which identified that the HRQoL of women living with endometriosis was poorly understood, with only three medical and one surgical study identified. OBJECTIVE AND RATIONALE: The 20-year anniversary of the EHP-30 provided a timely opportunity to assess how the tools have been used and explore what the findings tell us about the impact of endometriosis and its associated treatments upon women's QoL. Applying robust systematic review methodology, following PRISMA guidelines, we sought to answer: How many studies have used the EHP and for what purpose?; What are the demographic characteristics and international context of the studies?; What is the methodological nature and quality of the studies?; Which interventions have been assessed and what are the reported EHP outcomes?; and Can the EHP outcomes of these interventions be analysed using a meta-analysis and, if so, what do the results show? SEARCH METHODS: The electronic databases MEDLINE, CINAHL, PsycINFO, PubMed, and Google Scholar were searched from the year the EHP was first published, in 2001 to 26 February 2020 using the search terms 'EHP30', 'EHP5', 'EHP-30', 'EHP-5', 'endometriosis health profile 30', and 'endometriosis health profile 5'. We updated the searches on 9 April 2021. All included studies were quality assessed using the Mixed Methods Appraisal Tool (MMAT). OUTCOMES: The review included 139 papers. In clinical intervention studies, the EHPs were deployed most frequently to measure the outcomes of medical (n = 35) and surgical (n = 21) treatment. The EHPs were also used in 13 other intervention studies, 29 non-interventional studies, 32 psychometric/cross cultural validation studies; six diagnostic studies, and in three other studies to measure outcomes in related conditions. They were mainly deployed in studies undertaken in Europe and North America. Overall, regardless of the nature of the intervention, most women reported improvements in HRQoL after treatment. Surgical interventions generally resulted in significant improvements for the longest amount of time. There was also evidence that when participants stopped taking medication their EHP scores worsened, perhaps reinforcing the temporary impact of medical treatment. Younger patients reported more negative impact upon their HRQoL. Further evidence using classical test theory to support the EHPs' robust psychometric properties, including acceptability, dimensionality, reliability, validity (including cross-cultural), and responsiveness, was demonstrated, particularly for the EHP-30. Strikingly, using anchor-based methods, EHP-30 responsiveness studies demonstrate the largest mean changes in the 'control and powerlessness' domain post-intervention, followed by 'pain'. MMAT outcomes indicated the quality of the papers was good, with the exception of five studies. A meta-analysis was not undertaken owing to the heterogeneity of the interventions and papers included in this review. WIDER IMPLICATIONS: Women with endometriosis face a lifetime of surgical and/or medical interventions to keep the condition under control. Less invasive treatments that can lead to improved longer term physical and psycho-social outcomes are needed. The EHPs are reliable, valid, acceptable, and responsive tools, but more assessment of EHP outcomes using modern psychometric methods and in the context of women from ethnically diverse backgrounds and in routine clinical care would be beneficial. Given the brevity of the EHP-5, it may be the most appropriate version to use in routine clinical practice, whereas the longer EHP-30, which provides more granularity, is more appropriate for research.

来源:Hum Reprod Update,查看原文。版权归原作者所有。

引用

  1. Jones GL, Budds K, Taylor F, et al. A systematic review to determine use of the Endometriosis Health Profiles to measure quality of life outcomes in women with endometriosis. Hum Reprod Update. 2024. PMID: 38007607. doi:10.1093/humupd/dmad029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。